<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00886015</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00019216</org_study_id>
    <nct_id>NCT00886015</nct_id>
  </id_info>
  <brief_title>Modified Instrumentation for Surgery to Correct Trichiasis</brief_title>
  <official_title>Partnership for the Rapid Elimination of Trachoma (PRET) Clinical Trial of Evaluation of Modified Instrumentation for Surgery to Correct Trichiasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bill and Melinda Gates Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trachoma, an ocular infection caused by C. trachomatis, is the second leading infectious
      cause of blindness worldwide. Years of repeated infection with C. trachomatis cause the
      eyelid to scar and contract and ultimately to rotate inward such that the eyelashes rub
      against the eyeball and abrade the cornea (trichiasis). The World Health Organization (WHO)
      has endorsed a multi-faceted strategy to combat trachoma which includes surgery to repair
      lids distorted by trachoma (trichiasis) in imminent danger of vision loss. Current evidence
      suggests that long-term success rates of trichiasis surgery are less than optimal due to
      variation in surgical technique. Previous research by this study team has demonstrated that
      shorter incisions have a higher rate of trichiasis recurrence. In addition, observations by
      this team's oculoplastic surgeon have led to the hypothesis that granuloma formation and lid
      contour abnormalities may result from current surgical practices. The objective of this study
      is to compare outcomes of trichiasis surgeries performed with the newly developed
      trachomatous trichiasis (TT) clamp versus surgeries following standard technique (bilamellar
      tarsal rotation procedure or BLTR).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Field observations in 2005 by this study's PI and oculoplastic surgeon revealed some
      significant departures from current trichiasis surgery procedure (bilamellar tarsal rotation
      procedure or BTRP), as described in the WHO manual, &quot;Trichiasis Surgery for Trachoma-the
      Bilamellar Tarsal Rotation Procedure&quot;. These procedural departures were felt to contribute to
      adverse outcomes, including trichiasis recurrence, granuloma formation and lid contour
      abnormalities. This study team developed a new surgical tool, the TT clamp, to help improve
      surgical outcomes following BLTR.

      A randomized, single-masked clinical trial will be implemented in the Mtwara region in
      Tanzania. Study participants will be randomized on a 1:1 basis to surgery with the TT clamp
      or to surgery with standard BLTR equipment. All surgeries will take place at surgical centers
      in Mtwara and Lindi over an 8-month period.

      Baseline assessment for severity of trichiasis and other predictors of surgical failure will
      be carried out prior to surgery. Follow-up is planned at 2 weeks (for suture removal), 6
      weeks, 12 months, and 24 months post-surgery. At each follow-up visit participants will be
      assessed for evidence of unfavorable outcomes, including trichiasis recurrence, granuloma
      formation, and lid contour abnormalities. All outcomes will be assessed clinically by a
      trained observer who is masked to intervention status.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Eyelids With Presence of Recurrent Trichiasis</measure>
    <time_frame>2 years</time_frame>
    <description>Trichiasis: 1 or more eyelashes touching globe in primary position</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Eyelids With Pyogenic Granuloma</measure>
    <time_frame>2 years</time_frame>
    <description>A pyogenic granuloma was defined as a sessile growth of 2 mm or more in diameter on the tarsal conjunctiva.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Eyelids Experiencing an Unfavorable Outcome</measure>
    <time_frame>2 years</time_frame>
    <description>At least 1 unfavorable outcome, including mild, moderate, or severe trichiasis; granuloma; or mild, moderate, or severe eyelid contour abnormality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Eyelids With Normal or Mild Eyelid Contour Abnormalities vs Moderate or Severe Eyelid Contour Abnormalities</measure>
    <time_frame>2 years</time_frame>
    <description>Eyelid contour abnormalities (ECA) were graded by photographs of the eyes. In the primary outcome measure, normal eyes and mild eyelid contour abnormalities are considered together, and moderate or severe eyelid contour abnormalities are considered together. ECA severity is defined as follows:
Mild: Vertical deviation from the natural contour &lt; 1 mm in height (less than half the pupil height in daylight) and affecting &lt; 1/3 of horizontal eyelid length; Moderate: Vertical deviation from the natural contour 1-2 mm in height (about the pupil height in daylight) or affecting 1/3-2/3 of horizontal eyelid length; Severe: Vertical deviation from the natural contour &gt; 2 mm in height (more than the pupil height in daylight) or a defect &gt; 2/3 of the horizontal eyelid length</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Eyelids With Mild, Moderate, Severe, or no Eyelid Contour Abnormality</measure>
    <time_frame>2 years</time_frame>
    <description>Eyelid contour abnormalities (ECA) were graded by photographs of the eyes. ECA severity is defined as follows:
Mild: Vertical deviation from the natural contour &lt; 1 mm in height (less than half the pupil height in daylight) and affecting &lt; 1/3 of horizontal eyelid length; Moderate: Vertical deviation from the natural contour 1-2 mm in height (about the pupil height in daylight) or affecting 1/3-2/3 of horizontal eyelid length; Severe: Vertical deviation from the natural contour &gt; 2 mm in height (more than the pupil height in daylight) or a defect &gt; 2/3 of the horizontal eyelid length</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Eyelids With Normal, Mild, Moderate, or Severe Trachomatous Trichiasis</measure>
    <time_frame>2 Years</time_frame>
    <description>Trichiasis is generally defined as 1 or more eyelashes touching globe in primary position. Classifications of trichiasis severity are as follows:
Mild: 1-4 Eyelashes touching globe, no epilation OR 1-10 Eyelashes epilated, no eyelashes touching globe; Moderate: 5-9 Eyelashes touching globe, no epilation OR 1-4 Eyelashes touching globe and 1-10 eyelashes epilated; Severe: 5-9 Eyelashes touching globe and 1-10 eyelashes epilated OR 10 Eyelashes touching globe, regardless of epilation status OR 11-20 Eyelashes epilated, regardless of eyelashes touching globe OR Entire eyelid epilated, regardless of eyelashes touching globe</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1927</enrollment>
  <condition>Trachoma</condition>
  <arm_group>
    <arm_group_label>TT Clamp</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The TT clamp will be used in trichiasis surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard BLTR Technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard BLTR technique will be used in trichiasis surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TT Clamp</intervention_name>
    <description>trichiasis surgery performed with TT clamp</description>
    <arm_group_label>TT Clamp</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard BLTR Technique</intervention_name>
    <description>bilamellar tarsal rotation procedure in trichiasis surgery</description>
    <arm_group_label>Standard BLTR Technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of upper lid trichiasis: defined by at least one eyelash touching the globe
             of the eye or evidence of epilation

          -  No previous report of trichiasis surgery in at least one eye with trichiasis:

               -  eyes with prior surgery are already at high risk due to the prior surgery, and
                  their inclusion may decrease our ability to clearly evaluate our primary outcome

               -  if unilateral surgery has been performed previously, only the eye without prior
                  history of surgery will be in the study, even if both eyes require surgery

          -  Age 18 or older (in order to provide consent as an adult): the vast majority of
             trichiasis patients are aged 18 or older

          -  At time of enrollment, subjects must state their intention to remain in the area for
             two years to facilitate study follow-up

        Exclusion Criteria:

          -  Absence of upper lid trichiasis

          -  Prior trichiasis surgery on both eyes

          -  Age 18 or younger

          -  Subjects who are transiently in the area
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emily Gower, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2009</study_first_submitted>
  <study_first_submitted_qc>April 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2009</study_first_posted>
  <results_first_submitted>August 3, 2016</results_first_submitted>
  <results_first_submitted_qc>April 11, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 19, 2017</results_first_posted>
  <last_update_submitted>April 11, 2017</last_update_submitted>
  <last_update_submitted_qc>April 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Emily Gower</investigator_full_name>
    <investigator_title>Associate Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Trachoma</keyword>
  <keyword>trichiasis</keyword>
  <keyword>bilamellar tarsal rotation procedure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trachoma</mesh_term>
    <mesh_term>Trichiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified data will be provided to investigators through application to the data committee at Johns Hopkins University.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Community-level eye screenings were conducted to identify all trichiasis cases in the community. Patients were scheduled for surgery. On the day of surgery they were invited to join the study if they were eligible.</recruitment_details>
      <pre_assignment_details>963 individuals assigned to Trachomatous Trichiasis (TT) clamp, 6 did not participate. 3 refused surgery, 2 ineligible because of lower eyelid trichiasis only, 1 participant did not present for surgery.
964 individuals assigned to Standard, 4 did not participate. 2 refused surgery, 2 ineligible because of lower eyelid trichiasis only.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Standard Instrumentation</title>
          <description>Eyelids operated with standard BLTR instrumentation</description>
        </group>
        <group group_id="P2">
          <title>TT Clamp</title>
          <description>Eyelids operated with the TT clamp instead of standard BLTR instrumentation. The TT clamp replaces the 2 hemostats and lid plate</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1674">1674 eyes; 960 participants</participants>
                <participants group_id="P2" count="1671">1671 eyes; 957 participants</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1674">1674 eyes; 960 participants</participants>
                <participants group_id="P2" count="1669">1669 eyes; 956 participants</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>1927 participants were originally enrolled. 10 participants did not undergo surgery for the following reasons: refused surgery (5), ineligible because of lower eyelid trichiasis only (4), or surgery was delayed and patient did not attend (1). The final total number of participants was 1917.</population>
      <group_list>
        <group group_id="B1">
          <title>Standard Instrumentation</title>
          <description>Eyelids operated with standard BLTR instrumentation</description>
        </group>
        <group group_id="B2">
          <title>TT Clamp</title>
          <description>Eyelids operated with the TT clamp instead of standard BLTR instrumentation. The TT clamp replaces the 2 hemostats and lid plate</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="960"/>
            <count group_id="B2" value="957"/>
            <count group_id="B3" value="1917"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.6" spread="13.1"/>
                    <measurement group_id="B2" value="54.9" spread="13.5"/>
                    <measurement group_id="B3" value="55.2" spread="13.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="722"/>
                    <measurement group_id="B2" value="705"/>
                    <measurement group_id="B3" value="1427"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="238"/>
                    <measurement group_id="B2" value="252"/>
                    <measurement group_id="B3" value="490"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Tanzania</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="960"/>
                    <measurement group_id="B2" value="957"/>
                    <measurement group_id="B3" value="1917"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Trichiasis</title>
          <description>mild, moderate, severe</description>
          <units>eyelids</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="347"/>
                    <measurement group_id="B2" value="303"/>
                    <measurement group_id="B3" value="650"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="453"/>
                    <measurement group_id="B2" value="423"/>
                    <measurement group_id="B3" value="876"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="874"/>
                    <measurement group_id="B2" value="945"/>
                    <measurement group_id="B3" value="1819"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Eyelids With Presence of Recurrent Trichiasis</title>
        <description>Trichiasis: 1 or more eyelashes touching globe in primary position</description>
        <time_frame>2 years</time_frame>
        <population>Of the 1671 eyes initially assigned to TT Clamp, 1 participant (2 eyelids) was excluded from TT Clamp analysis because participant died before follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>TT Clamp</title>
            <description>The TT clamp will be used in trichiasis surgery.
TT Clamp: trichiasis surgery performed with TT clamp</description>
          </group>
          <group group_id="O2">
            <title>Standard BLTR Technique</title>
            <description>Standard BLTR technique will be used in trichiasis surgery.
Standard BLTR Technique: bilamellar tarsal rotation procedure in trichiasis surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Eyelids With Presence of Recurrent Trichiasis</title>
          <description>Trichiasis: 1 or more eyelashes touching globe in primary position</description>
          <population>Of the 1671 eyes initially assigned to TT Clamp, 1 participant (2 eyelids) was excluded from TT Clamp analysis because participant died before follow-up.</population>
          <units>eyelids</units>
          <param>Number</param>
          <units_analyzed>eyelids</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
                <count group_id="O2" value="960"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyelids</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1669"/>
                <count group_id="O2" value="1674"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Normal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="948"/>
                    <measurement group_id="O2" value="1062"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TT Recurrence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="721"/>
                    <measurement group_id="O2" value="612"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.36</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.96</ci_lower_limit>
            <ci_upper_limit>1.93</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Eyelids With Pyogenic Granuloma</title>
        <description>A pyogenic granuloma was defined as a sessile growth of 2 mm or more in diameter on the tarsal conjunctiva.</description>
        <time_frame>2 years</time_frame>
        <population>Of the original 1771 eyelids assigned to TT clamp, 1 participant (2 eyelids) was excluded from TT Clamp analysis because participant died before follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>TT Clamp</title>
            <description>The TT clamp will be used in trichiasis surgery.
TT Clamp: trichiasis surgery performed with TT clamp</description>
          </group>
          <group group_id="O2">
            <title>Standard BLTR Technique</title>
            <description>Standard BLTR technique will be used in trichiasis surgery.
Standard BLTR Technique: bilamellar tarsal rotation procedure in trichiasis surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Eyelids With Pyogenic Granuloma</title>
          <description>A pyogenic granuloma was defined as a sessile growth of 2 mm or more in diameter on the tarsal conjunctiva.</description>
          <population>Of the original 1771 eyelids assigned to TT clamp, 1 participant (2 eyelids) was excluded from TT Clamp analysis because participant died before follow-up</population>
          <units>eyelids</units>
          <param>Number</param>
          <units_analyzed>eyelids</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
                <count group_id="O2" value="960"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyelids</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1669"/>
                <count group_id="O2" value="1674"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Granuloma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="281"/>
                    <measurement group_id="O2" value="375"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1388"/>
                    <measurement group_id="O2" value="1299"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.67</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.46</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Eyelids Experiencing an Unfavorable Outcome</title>
        <description>At least 1 unfavorable outcome, including mild, moderate, or severe trichiasis; granuloma; or mild, moderate, or severe eyelid contour abnormality</description>
        <time_frame>2 years</time_frame>
        <population>Of the original 1771 eyelids assigned to TT clamp, 1 participant (2 eyelids) was excluded from TT Clamp analysis because participant died before follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>TT Clamp</title>
            <description>The TT clamp will be used in trichiasis surgery.
TT Clamp: trichiasis surgery performed with TT clamp</description>
          </group>
          <group group_id="O2">
            <title>Standard BLTR Technique</title>
            <description>Standard BLTR technique will be used in trichiasis surgery.
Standard BLTR Technique: bilamellar tarsal rotation procedure in trichiasis surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Eyelids Experiencing an Unfavorable Outcome</title>
          <description>At least 1 unfavorable outcome, including mild, moderate, or severe trichiasis; granuloma; or mild, moderate, or severe eyelid contour abnormality</description>
          <population>Of the original 1771 eyelids assigned to TT clamp, 1 participant (2 eyelids) was excluded from TT Clamp analysis because participant died before follow-up</population>
          <units>eyelids</units>
          <param>Number</param>
          <units_analyzed>eyelids</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
                <count group_id="O2" value="960"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyelids</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1669"/>
                <count group_id="O2" value="1674"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any unfavorable outcome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1017"/>
                    <measurement group_id="O2" value="1055"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="652"/>
                    <measurement group_id="O2" value="619"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.88</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.66</ci_lower_limit>
            <ci_upper_limit>1.18</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Eyelids With Normal or Mild Eyelid Contour Abnormalities vs Moderate or Severe Eyelid Contour Abnormalities</title>
        <description>Eyelid contour abnormalities (ECA) were graded by photographs of the eyes. In the primary outcome measure, normal eyes and mild eyelid contour abnormalities are considered together, and moderate or severe eyelid contour abnormalities are considered together. ECA severity is defined as follows:
Mild: Vertical deviation from the natural contour &lt; 1 mm in height (less than half the pupil height in daylight) and affecting &lt; 1/3 of horizontal eyelid length; Moderate: Vertical deviation from the natural contour 1–2 mm in height (about the pupil height in daylight) or affecting 1/3–2/3 of horizontal eyelid length; Severe: Vertical deviation from the natural contour &gt; 2 mm in height (more than the pupil height in daylight) or a defect &gt; 2/3 of the horizontal eyelid length</description>
        <time_frame>2 years</time_frame>
        <population>Of the original 1771 eyelids assigned to TT clamp, 1 participant (2 eyelids) was excluded from TT Clamp analysis because participant died before follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>TT Clamp</title>
            <description>The TT clamp will be used in trichiasis surgery.
TT Clamp: trichiasis surgery performed with TT clamp</description>
          </group>
          <group group_id="O2">
            <title>Standard BLTR Technique</title>
            <description>Standard BLTR technique will be used in trichiasis surgery.
Standard BLTR Technique: bilamellar tarsal rotation procedure in trichiasis surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Eyelids With Normal or Mild Eyelid Contour Abnormalities vs Moderate or Severe Eyelid Contour Abnormalities</title>
          <description>Eyelid contour abnormalities (ECA) were graded by photographs of the eyes. In the primary outcome measure, normal eyes and mild eyelid contour abnormalities are considered together, and moderate or severe eyelid contour abnormalities are considered together. ECA severity is defined as follows:
Mild: Vertical deviation from the natural contour &lt; 1 mm in height (less than half the pupil height in daylight) and affecting &lt; 1/3 of horizontal eyelid length; Moderate: Vertical deviation from the natural contour 1–2 mm in height (about the pupil height in daylight) or affecting 1/3–2/3 of horizontal eyelid length; Severe: Vertical deviation from the natural contour &gt; 2 mm in height (more than the pupil height in daylight) or a defect &gt; 2/3 of the horizontal eyelid length</description>
          <population>Of the original 1771 eyelids assigned to TT clamp, 1 participant (2 eyelids) was excluded from TT Clamp analysis because participant died before follow-up</population>
          <units>eyelids</units>
          <param>Number</param>
          <units_analyzed>eyelids</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
                <count group_id="O2" value="960"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyelids</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1669"/>
                <count group_id="O2" value="1674"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>No/Mild ECA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1549"/>
                    <measurement group_id="O2" value="1500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate/Severe ECA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120"/>
                    <measurement group_id="O2" value="174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.65</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.44</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Eyelids With Mild, Moderate, Severe, or no Eyelid Contour Abnormality</title>
        <description>Eyelid contour abnormalities (ECA) were graded by photographs of the eyes. ECA severity is defined as follows:
Mild: Vertical deviation from the natural contour &lt; 1 mm in height (less than half the pupil height in daylight) and affecting &lt; 1/3 of horizontal eyelid length; Moderate: Vertical deviation from the natural contour 1–2 mm in height (about the pupil height in daylight) or affecting 1/3–2/3 of horizontal eyelid length; Severe: Vertical deviation from the natural contour &gt; 2 mm in height (more than the pupil height in daylight) or a defect &gt; 2/3 of the horizontal eyelid length</description>
        <time_frame>2 years</time_frame>
        <population>Of the 1771 participants originally assigned to TT Clamp, 1 participant (2 eyelids) was excluded from TT Clamp analysis because participant died before follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>TT Clamp</title>
            <description>The TT clamp will be used in trichiasis surgery.
TT Clamp: trichiasis surgery performed with TT clamp</description>
          </group>
          <group group_id="O2">
            <title>Standard BLTR Technique</title>
            <description>Standard BLTR technique will be used in trichiasis surgery.
Standard BLTR Technique: bilamellar tarsal rotation procedure in trichiasis surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Eyelids With Mild, Moderate, Severe, or no Eyelid Contour Abnormality</title>
          <description>Eyelid contour abnormalities (ECA) were graded by photographs of the eyes. ECA severity is defined as follows:
Mild: Vertical deviation from the natural contour &lt; 1 mm in height (less than half the pupil height in daylight) and affecting &lt; 1/3 of horizontal eyelid length; Moderate: Vertical deviation from the natural contour 1–2 mm in height (about the pupil height in daylight) or affecting 1/3–2/3 of horizontal eyelid length; Severe: Vertical deviation from the natural contour &gt; 2 mm in height (more than the pupil height in daylight) or a defect &gt; 2/3 of the horizontal eyelid length</description>
          <population>Of the 1771 participants originally assigned to TT Clamp, 1 participant (2 eyelids) was excluded from TT Clamp analysis because participant died before follow-up</population>
          <units>eyelids</units>
          <param>Number</param>
          <units_analyzed>eyelids</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
                <count group_id="O2" value="960"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyelids</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1669"/>
                <count group_id="O2" value="1674"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Normal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1397"/>
                    <measurement group_id="O2" value="1278"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mild ECA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="152"/>
                    <measurement group_id="O2" value="222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate ECA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89"/>
                    <measurement group_id="O2" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe ECA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mild ECA compared with Normal</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.64</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.42</ci_lower_limit>
            <ci_upper_limit>0.97</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Moderate ECA compared with Normal</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.63</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.39</ci_lower_limit>
            <ci_upper_limit>1.01</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Severe ECA compared with Normal</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.62</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.35</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Eyelids With Normal, Mild, Moderate, or Severe Trachomatous Trichiasis</title>
        <description>Trichiasis is generally defined as 1 or more eyelashes touching globe in primary position. Classifications of trichiasis severity are as follows:
Mild: 1-4 Eyelashes touching globe, no epilation OR 1-10 Eyelashes epilated, no eyelashes touching globe; Moderate: 5-9 Eyelashes touching globe, no epilation OR 1-4 Eyelashes touching globe and 1-10 eyelashes epilated; Severe: 5-9 Eyelashes touching globe and 1-10 eyelashes epilated OR 10 Eyelashes touching globe, regardless of epilation status OR 11-20 Eyelashes epilated, regardless of eyelashes touching globe OR Entire eyelid epilated, regardless of eyelashes touching globe</description>
        <time_frame>2 Years</time_frame>
        <population>Of the 1669 TT eyelids and 1674 BLTR eyelids included in the initial analysis, 13 eyes (4 in the TT clamp group, 9 in the BLTR group) without TT at 1 year underwent operation between years 1 and 2. They are not included in the data for severity of recurrence because we do not know the TT severity.</population>
        <group_list>
          <group group_id="O1">
            <title>TT Clamp</title>
            <description>The TT clamp will be used in trichiasis surgery.
TT Clamp: trichiasis surgery performed with TT clamp</description>
          </group>
          <group group_id="O2">
            <title>Standard BLTR Technique</title>
            <description>Standard BLTR technique will be used in trichiasis surgery.
Standard BLTR Technique: bilamellar tarsal rotation procedure in trichiasis surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Eyelids With Normal, Mild, Moderate, or Severe Trachomatous Trichiasis</title>
          <description>Trichiasis is generally defined as 1 or more eyelashes touching globe in primary position. Classifications of trichiasis severity are as follows:
Mild: 1-4 Eyelashes touching globe, no epilation OR 1-10 Eyelashes epilated, no eyelashes touching globe; Moderate: 5-9 Eyelashes touching globe, no epilation OR 1-4 Eyelashes touching globe and 1-10 eyelashes epilated; Severe: 5-9 Eyelashes touching globe and 1-10 eyelashes epilated OR 10 Eyelashes touching globe, regardless of epilation status OR 11-20 Eyelashes epilated, regardless of eyelashes touching globe OR Entire eyelid epilated, regardless of eyelashes touching globe</description>
          <population>Of the 1669 TT eyelids and 1674 BLTR eyelids included in the initial analysis, 13 eyes (4 in the TT clamp group, 9 in the BLTR group) without TT at 1 year underwent operation between years 1 and 2. They are not included in the data for severity of recurrence because we do not know the TT severity.</population>
          <units>eyelids</units>
          <param>Number</param>
          <units_analyzed>eyelids</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="954"/>
                <count group_id="O2" value="956"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyelids</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1665"/>
                <count group_id="O2" value="1665"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Normal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="948"/>
                    <measurement group_id="O2" value="1062"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mild TT Recurrence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="476"/>
                    <measurement group_id="O2" value="417"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate TT Recurrence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121"/>
                    <measurement group_id="O2" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe TT Recurrence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120"/>
                    <measurement group_id="O2" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.22</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.97</ci_lower_limit>
            <ci_upper_limit>1.53</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>through 2 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard Instrumentation</title>
          <description>Eyelids operated with standard BLTR instrumentation</description>
        </group>
        <group group_id="E2">
          <title>TT Clamp</title>
          <description>Eyelids operated with the TT clamp instead of standard BLTR instrumentation. The TT clamp replaces the 2 hemostats and lid plate</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="960"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="957"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="960"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="957"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Excess intraoperative bleeding</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="960"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="957"/>
              </event>
              <event>
                <sub_title>Division of Eyelid Margin</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="960"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="957"/>
              </event>
              <event>
                <sub_title>postoperative bleeding</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="960"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="957"/>
              </event>
              <event>
                <sub_title>necrosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="960"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="957"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sheila West</name_or_title>
      <organization>JohnHopkins U</organization>
      <phone>410-955-2606</phone>
      <email>shwest@jhmi.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

